USA – According to a news release from, Merck, the Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) for the treatment of patients with advanced endometrial carcinoma that is…
Read MoreUS FDA approves Keytruda monotherapy for endometrial cancer
